nodes	percent_of_prediction	percent_of_DWPC	metapath
Mefloquine—CYP19A1—gestational diabetes	0.865	1	CbGaD
Mefloquine—ABCB1—Glyburide—gestational diabetes	0.0322	0.625	CbGbCtD
Mefloquine—CYP3A4—Glyburide—gestational diabetes	0.0193	0.375	CbGbCtD
Mefloquine—HBA2—embryo—gestational diabetes	0.00501	0.153	CbGeAlD
Mefloquine—Encephalopathy—Glyburide—gestational diabetes	0.00365	0.0847	CcSEcCtD
Mefloquine—HBA1—adipose tissue—gestational diabetes	0.0036	0.11	CbGeAlD
Mefloquine—HBA2—adipose tissue—gestational diabetes	0.0033	0.101	CbGeAlD
Mefloquine—HBA1—head—gestational diabetes	0.00276	0.0842	CbGeAlD
Mefloquine—HBA2—head—gestational diabetes	0.00253	0.0773	CbGeAlD
Mefloquine—ACHE—islet of Langerhans—gestational diabetes	0.00231	0.0705	CbGeAlD
Mefloquine—Aplastic anaemia—Glyburide—gestational diabetes	0.0022	0.0511	CcSEcCtD
Mefloquine—Deafness—Glyburide—gestational diabetes	0.0019	0.0441	CcSEcCtD
Mefloquine—Hepatic failure—Glyburide—gestational diabetes	0.00189	0.0439	CcSEcCtD
Mefloquine—Visual disturbance—Glyburide—gestational diabetes	0.00179	0.0417	CcSEcCtD
Mefloquine—Dermatitis bullous—Glyburide—gestational diabetes	0.00178	0.0413	CcSEcCtD
Mefloquine—ADORA1—adipose tissue—gestational diabetes	0.00148	0.0452	CbGeAlD
Mefloquine—ADORA2A—head—gestational diabetes	0.00132	0.0402	CbGeAlD
Mefloquine—ADORA1—vagina—gestational diabetes	0.00123	0.0376	CbGeAlD
Mefloquine—Agranulocytosis—Glyburide—gestational diabetes	0.00122	0.0284	CcSEcCtD
Mefloquine—ADORA1—head—gestational diabetes	0.00114	0.0347	CbGeAlD
Mefloquine—Visual impairment—Glyburide—gestational diabetes	0.00113	0.0263	CcSEcCtD
Mefloquine—Eye disorder—Glyburide—gestational diabetes	0.0011	0.0255	CcSEcCtD
Mefloquine—Alopecia—Glyburide—gestational diabetes	0.00104	0.0241	CcSEcCtD
Mefloquine—CYP19A1—uterus—gestational diabetes	0.00103	0.0314	CbGeAlD
Mefloquine—Malnutrition—Glyburide—gestational diabetes	0.00102	0.0238	CcSEcCtD
Mefloquine—Erythema—Glyburide—gestational diabetes	0.00102	0.0238	CcSEcCtD
Mefloquine—CYP19A1—adipose tissue—gestational diabetes	0.00101	0.0307	CbGeAlD
Mefloquine—Vision blurred—Glyburide—gestational diabetes	0.000965	0.0224	CcSEcCtD
Mefloquine—Tremor—Glyburide—gestational diabetes	0.000959	0.0223	CcSEcCtD
Mefloquine—Leukopenia—Glyburide—gestational diabetes	0.000916	0.0213	CcSEcCtD
Mefloquine—Convulsion—Glyburide—gestational diabetes	0.000887	0.0206	CcSEcCtD
Mefloquine—Arthralgia—Glyburide—gestational diabetes	0.000871	0.0202	CcSEcCtD
Mefloquine—Myalgia—Glyburide—gestational diabetes	0.000871	0.0202	CcSEcCtD
Mefloquine—Confusional state—Glyburide—gestational diabetes	0.000842	0.0196	CcSEcCtD
Mefloquine—Oedema—Glyburide—gestational diabetes	0.000835	0.0194	CcSEcCtD
Mefloquine—Shock—Glyburide—gestational diabetes	0.000822	0.0191	CcSEcCtD
Mefloquine—Nervous system disorder—Glyburide—gestational diabetes	0.000819	0.019	CcSEcCtD
Mefloquine—Thrombocytopenia—Glyburide—gestational diabetes	0.000818	0.019	CcSEcCtD
Mefloquine—Hyperhidrosis—Glyburide—gestational diabetes	0.000808	0.0188	CcSEcCtD
Mefloquine—Hypotension—Glyburide—gestational diabetes	0.000781	0.0181	CcSEcCtD
Mefloquine—CYP19A1—head—gestational diabetes	0.000773	0.0235	CbGeAlD
Mefloquine—Musculoskeletal discomfort—Glyburide—gestational diabetes	0.000761	0.0177	CcSEcCtD
Mefloquine—Paraesthesia—Glyburide—gestational diabetes	0.00075	0.0174	CcSEcCtD
Mefloquine—Dyspnoea—Glyburide—gestational diabetes	0.000745	0.0173	CcSEcCtD
Mefloquine—BCHE—uterus—gestational diabetes	0.000741	0.0226	CbGeAlD
Mefloquine—Dyspepsia—Glyburide—gestational diabetes	0.000735	0.0171	CcSEcCtD
Mefloquine—Decreased appetite—Glyburide—gestational diabetes	0.000726	0.0169	CcSEcCtD
Mefloquine—BCHE—adipose tissue—gestational diabetes	0.000725	0.0221	CbGeAlD
Mefloquine—Gastrointestinal disorder—Glyburide—gestational diabetes	0.000721	0.0167	CcSEcCtD
Mefloquine—Feeling abnormal—Glyburide—gestational diabetes	0.000688	0.016	CcSEcCtD
Mefloquine—Gastrointestinal pain—Glyburide—gestational diabetes	0.000683	0.0159	CcSEcCtD
Mefloquine—Urticaria—Glyburide—gestational diabetes	0.000664	0.0154	CcSEcCtD
Mefloquine—Abdominal pain—Glyburide—gestational diabetes	0.00066	0.0153	CcSEcCtD
Mefloquine—Hypersensitivity—Glyburide—gestational diabetes	0.000615	0.0143	CcSEcCtD
Mefloquine—BCHE—vagina—gestational diabetes	0.000602	0.0184	CbGeAlD
Mefloquine—Asthenia—Glyburide—gestational diabetes	0.000599	0.0139	CcSEcCtD
Mefloquine—Pruritus—Glyburide—gestational diabetes	0.000591	0.0137	CcSEcCtD
Mefloquine—Diarrhoea—Glyburide—gestational diabetes	0.000572	0.0133	CcSEcCtD
Mefloquine—BCHE—head—gestational diabetes	0.000556	0.017	CbGeAlD
Mefloquine—ABCB1—islet of Langerhans—gestational diabetes	0.000542	0.0165	CbGeAlD
Mefloquine—Vomiting—Glyburide—gestational diabetes	0.000531	0.0123	CcSEcCtD
Mefloquine—Rash—Glyburide—gestational diabetes	0.000527	0.0122	CcSEcCtD
Mefloquine—Dermatitis—Glyburide—gestational diabetes	0.000526	0.0122	CcSEcCtD
Mefloquine—ABCB1—embryo—gestational diabetes	0.000524	0.016	CbGeAlD
Mefloquine—Headache—Glyburide—gestational diabetes	0.000523	0.0122	CcSEcCtD
Mefloquine—Nausea—Glyburide—gestational diabetes	0.000496	0.0115	CcSEcCtD
Mefloquine—CYP2D6—head—gestational diabetes	0.000369	0.0112	CbGeAlD
Mefloquine—ABCB1—uterus—gestational diabetes	0.000353	0.0108	CbGeAlD
Mefloquine—ABCB1—adipose tissue—gestational diabetes	0.000345	0.0105	CbGeAlD
Mefloquine—ACHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—gestational diabetes	0.000321	0.0438	CbGpPWpGaD
Mefloquine—HBA1—Vitamin B12 Metabolism—TNF—gestational diabetes	0.000307	0.0418	CbGpPWpGaD
Mefloquine—ABCB1—vagina—gestational diabetes	0.000287	0.00875	CbGeAlD
Mefloquine—BCHE—Synthesis, secretion, and deacylation of Ghrelin—LEP—gestational diabetes	0.000286	0.039	CbGpPWpGaD
Mefloquine—ABCB1—head—gestational diabetes	0.000265	0.00808	CbGeAlD
Mefloquine—HBA1—Folate Metabolism—TNF—gestational diabetes	0.000249	0.034	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—GGCT—gestational diabetes	0.000232	0.0317	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—GLS2—gestational diabetes	0.000203	0.0277	CbGpPWpGaD
Mefloquine—HBA1—Selenium Micronutrient Network—TNF—gestational diabetes	0.000198	0.027	CbGpPWpGaD
Mefloquine—CYP19A1—Biological oxidations—GGCT—gestational diabetes	0.00019	0.0259	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—GGCT—gestational diabetes	0.000176	0.024	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—MTNR1B—gestational diabetes	0.000162	0.0221	CbGpPWpGaD
Mefloquine—ACHE—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.00016	0.0219	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—GLS2—gestational diabetes	0.000154	0.021	CbGpPWpGaD
Mefloquine—ADORA1—G alpha (i) signalling events—MTNR1B—gestational diabetes	0.000143	0.0195	CbGpPWpGaD
Mefloquine—BCHE—Transmission across Chemical Synapses—GLS2—gestational diabetes	0.000143	0.0195	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—NAMPT—gestational diabetes	0.000142	0.0194	CbGpPWpGaD
Mefloquine—ADORA1—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000133	0.0181	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—MTNR1B—gestational diabetes	0.000125	0.0171	CbGpPWpGaD
Mefloquine—ACHE—Neuronal System—GLS2—gestational diabetes	0.000123	0.0168	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—ADIPOQ—gestational diabetes	0.000116	0.0158	CbGpPWpGaD
Mefloquine—ADORA1—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	0.000114	0.0155	CbGpPWpGaD
Mefloquine—ADORA2A—Monoamine Transport—TNF—gestational diabetes	0.000112	0.0153	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—NAMPT—gestational diabetes	0.000111	0.0152	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—GCK—gestational diabetes	0.000111	0.0151	CbGpPWpGaD
Mefloquine—BCHE—Neuronal System—GLS2—gestational diabetes	0.00011	0.0149	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—NAMPT—gestational diabetes	0.00011	0.0149	CbGpPWpGaD
Mefloquine—ADORA2A—GPCRs, Class A Rhodopsin-like—MTNR1B—gestational diabetes	0.000103	0.014	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	9.22e-05	0.0126	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—ADIPOQ—gestational diabetes	8.96e-05	0.0122	CbGpPWpGaD
Mefloquine—ACHE—Monoamine Transport—TNF—gestational diabetes	8.95e-05	0.0122	CbGpPWpGaD
Mefloquine—ACHE—Peptide hormone metabolism—LEP—gestational diabetes	8.85e-05	0.0121	CbGpPWpGaD
Mefloquine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—MTNR1B—gestational diabetes	8.79e-05	0.012	CbGpPWpGaD
Mefloquine—ADORA1—GPCR ligand binding—MTNR1B—gestational diabetes	8.67e-05	0.0118	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—GGCT—gestational diabetes	8.49e-05	0.0116	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—NAMPT—gestational diabetes	8.43e-05	0.0115	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—GCK—gestational diabetes	8.38e-05	0.0114	CbGpPWpGaD
Mefloquine—HBA2—Metabolism—CYP19A1—gestational diabetes	8.08e-05	0.011	CbGpPWpGaD
Mefloquine—BCHE—Peptide hormone metabolism—LEP—gestational diabetes	7.9e-05	0.0108	CbGpPWpGaD
Mefloquine—ADORA1—Circadian rythm related genes—LEP—gestational diabetes	7.21e-05	0.00984	CbGpPWpGaD
Mefloquine—CYP19A1—Integrated Breast Cancer Pathway—AR—gestational diabetes	7.14e-05	0.00974	CbGpPWpGaD
Mefloquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	6.86e-05	0.00935	CbGpPWpGaD
Mefloquine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	6.77e-05	0.00923	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR ligand binding—MTNR1B—gestational diabetes	6.69e-05	0.00913	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	6.44e-05	0.00879	CbGpPWpGaD
Mefloquine—HBA1—Metabolism—CYP19A1—gestational diabetes	6.13e-05	0.00836	CbGpPWpGaD
Mefloquine—ADORA2A—Circadian rythm related genes—LEP—gestational diabetes	5.57e-05	0.00759	CbGpPWpGaD
Mefloquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	5.56e-05	0.00758	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—GGCT—gestational diabetes	5.55e-05	0.00757	CbGpPWpGaD
Mefloquine—CYP3A4—Tryptophan metabolism—CYP19A1—gestational diabetes	5.55e-05	0.00756	CbGpPWpGaD
Mefloquine—ADORA1—GPCR downstream signaling—MTNR1B—gestational diabetes	4.9e-05	0.00668	CbGpPWpGaD
Mefloquine—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	4.72e-05	0.00644	CbGpPWpGaD
Mefloquine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—gestational diabetes	4.48e-05	0.00612	CbGpPWpGaD
Mefloquine—ADORA1—Signaling by GPCR—MTNR1B—gestational diabetes	4.45e-05	0.00607	CbGpPWpGaD
Mefloquine—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—gestational diabetes	4.42e-05	0.00604	CbGpPWpGaD
Mefloquine—ADORA2A—NGF signalling via TRKA from the plasma membrane—FGF2—gestational diabetes	4.15e-05	0.00566	CbGpPWpGaD
Mefloquine—ADORA2A—GPCR downstream signaling—MTNR1B—gestational diabetes	3.78e-05	0.00516	CbGpPWpGaD
Mefloquine—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—gestational diabetes	3.63e-05	0.00496	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GGCT—gestational diabetes	3.54e-05	0.00483	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	3.52e-05	0.0048	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by GPCR—MTNR1B—gestational diabetes	3.44e-05	0.00469	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—LEPR—gestational diabetes	3.33e-05	0.00454	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GGCT—gestational diabetes	3.25e-05	0.00444	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling by NGF—FGF2—gestational diabetes	3.19e-05	0.00435	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GGCT—gestational diabetes	3.16e-05	0.00431	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GLS2—gestational diabetes	3.09e-05	0.00422	CbGpPWpGaD
Mefloquine—CYP2D6—Biological oxidations—CYP19A1—gestational diabetes	2.95e-05	0.00403	CbGpPWpGaD
Mefloquine—CYP2D6—Metapathway biotransformation—CYP19A1—gestational diabetes	2.91e-05	0.00397	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GLS2—gestational diabetes	2.84e-05	0.00388	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	2.8e-05	0.00382	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.76e-05	0.00377	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GLS2—gestational diabetes	2.76e-05	0.00376	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—MTNR1B—gestational diabetes	2.63e-05	0.00359	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LEPR—gestational diabetes	2.57e-05	0.0035	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—RBP4—gestational diabetes	2.56e-05	0.00349	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of lipids and lipoproteins—CYP19A1—gestational diabetes	2.47e-05	0.00336	CbGpPWpGaD
Mefloquine—ACHE—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	2.14e-05	0.00292	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—MTNR1B—gestational diabetes	2.03e-05	0.00277	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—RBP4—gestational diabetes	1.98e-05	0.0027	CbGpPWpGaD
Mefloquine—CYP3A4—Biological oxidations—CYP19A1—gestational diabetes	1.93e-05	0.00263	CbGpPWpGaD
Mefloquine—CYP3A4—Metapathway biotransformation—CYP19A1—gestational diabetes	1.9e-05	0.0026	CbGpPWpGaD
Mefloquine—ABCB1—Allograft Rejection—TNF—gestational diabetes	1.89e-05	0.00258	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—NAMPT—gestational diabetes	1.69e-05	0.00231	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—GCK—gestational diabetes	1.68e-05	0.0023	CbGpPWpGaD
Mefloquine—ACHE—Metabolism of proteins—LEP—gestational diabetes	1.67e-05	0.00228	CbGpPWpGaD
Mefloquine—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	1.56e-05	0.00213	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—NAMPT—gestational diabetes	1.56e-05	0.00212	CbGpPWpGaD
Mefloquine—CYP19A1—Metabolism—GCK—gestational diabetes	1.55e-05	0.00211	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GGCT—gestational diabetes	1.54e-05	0.0021	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	1.53e-05	0.00209	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—NAMPT—gestational diabetes	1.51e-05	0.00206	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—GCK—gestational diabetes	1.5e-05	0.00205	CbGpPWpGaD
Mefloquine—BCHE—Metabolism of proteins—LEP—gestational diabetes	1.49e-05	0.00203	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GGCT—gestational diabetes	1.45e-05	0.00198	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GLS2—gestational diabetes	1.35e-05	0.00184	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GLS2—gestational diabetes	1.27e-05	0.00173	CbGpPWpGaD
Mefloquine—ACHE—Metabolism—CYP19A1—gestational diabetes	1.23e-05	0.00168	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—LEP—gestational diabetes	1.17e-05	0.00159	CbGpPWpGaD
Mefloquine—BCHE—Metabolism—CYP19A1—gestational diabetes	1.1e-05	0.0015	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GGCT—gestational diabetes	9.49e-06	0.00129	CbGpPWpGaD
Mefloquine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	9.33e-06	0.00127	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—LEP—gestational diabetes	9.02e-06	0.00123	CbGpPWpGaD
Mefloquine—ADORA1—Signaling Pathways—FGF2—gestational diabetes	8.87e-06	0.00121	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GLS2—gestational diabetes	8.29e-06	0.00113	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—NAMPT—gestational diabetes	7.38e-06	0.00101	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—GCK—gestational diabetes	7.33e-06	0.001	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—NAMPT—gestational diabetes	6.95e-06	0.000948	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—GCK—gestational diabetes	6.91e-06	0.000942	CbGpPWpGaD
Mefloquine—ADORA2A—Signaling Pathways—FGF2—gestational diabetes	6.85e-06	0.000934	CbGpPWpGaD
Mefloquine—ABCB1—Metabolism—CYP19A1—gestational diabetes	5.36e-06	0.000731	CbGpPWpGaD
Mefloquine—CYP2D6—Metabolism—CYP19A1—gestational diabetes	5.05e-06	0.000689	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—NAMPT—gestational diabetes	4.54e-06	0.00062	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—GCK—gestational diabetes	4.52e-06	0.000616	CbGpPWpGaD
Mefloquine—CYP3A4—Metabolism—CYP19A1—gestational diabetes	3.3e-06	0.00045	CbGpPWpGaD
